Evaluation of Femaxeen® for control of urinary incontinence in women: A randomized, double-blind, placebo-controlled study.
- 2020-03
- RCT · n = 81
- Maturitas 133
- Santiago Palacios
- Marieta Ramirez
- Mariella Lilue
- Barbara Vega
- PubMed: 32005419
- DOI: 10.1016/j.maturitas.2019.12.008
- High evidence
- Clinical
Femaxeen produced statistically significant improvements from baseline to Day 90 (p < 0.001 for all comparisons) in scores on the Sandvik Incontinence Severity Index
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- once daily